These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21954818)

  • 21. Targeted therapies: a new generation of cancer treatments.
    Gerber DE
    Am Fam Physician; 2008 Feb; 77(3):311-9. PubMed ID: 18297955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the vascular endothelial growth factor pathway in the treatment of human malignancy.
    Tonra JR; Hicklin DJ
    Immunol Invest; 2007; 36(1):3-23. PubMed ID: 17190647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension.
    Versmissen J; Mirabito Colafella KM; Koolen SLW; Danser AHJ
    Cardiovasc Res; 2019 Apr; 115(5):904-914. PubMed ID: 30726882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Antihypertensive Drugs in Neoplastic Patients.
    Rizzoni D; De Ciuceis C; Porteri E; Agabiti-Rosei C; Agabiti-Rosei E
    High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):127-132. PubMed ID: 28361339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy.
    Levine AM; Tulpule A; Quinn DI; Gorospe G; Smith DL; Hornor L; Boswell WD; Espina BM; Groshen SG; Masood R; Gill PS
    J Clin Oncol; 2006 Apr; 24(11):1712-9. PubMed ID: 16520466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biology of anti-angiogenic therapy-induced thrombotic microangiopathy.
    Eremina V; Quaggin SE
    Semin Nephrol; 2010 Nov; 30(6):582-90. PubMed ID: 21146123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Novel angiogenesis inhibitors for molecular target therapy of cancer].
    Osada H; Kakeya H
    Nihon Rinsho; 2004 Jul; 62(7):1257-63. PubMed ID: 15283141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic and kidney toxicity of intraocular administration of vascular endothelial growth factor inhibitors.
    Pellé G; Shweke N; Duong Van Huyen JP; Tricot L; Hessaïne S; Frémeaux-Bacchi V; Hiesse C; Delahousse M
    Am J Kidney Dis; 2011 May; 57(5):756-9. PubMed ID: 21295897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
    Tuñón J; Ruiz-Moreno JM; Martín-Ventura JL; Blanco-Colio LM; Lorenzo O; Egido J
    Surv Ophthalmol; 2009; 54(3):339-48. PubMed ID: 19422962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome.
    Small HY; Montezano AC; Rios FJ; Savoia C; Touyz RM
    Can J Cardiol; 2014 May; 30(5):534-43. PubMed ID: 24786444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of hypertension and heart failure due to antiangiogenic cancer therapies.
    Rees ML; Khakoo AY
    Heart Fail Clin; 2011 Jul; 7(3):299-311. PubMed ID: 21749882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nephrotoxicity--proteinuria and hypertension--].
    Ando M
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1649-53. PubMed ID: 18931564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors.
    Eskens FA; Steeghs N; Verweij J; Bloem JL; Christensen O; van Doorn L; Ouwerkerk J; de Jonge MJ; Nortier JW; Kraetzschmar J; Rajagopalan P; Gelderblom H
    J Clin Oncol; 2009 Sep; 27(25):4169-76. PubMed ID: 19636022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenesis inhibitors in the treatment of lung cancer.
    Sun S; Schiller JH
    Crit Rev Oncol Hematol; 2007 May; 62(2):93-104. PubMed ID: 17306557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
    Steingart RM; Bakris GL; Chen HX; Chen MH; Force T; Ivy SP; Leier CV; Liu G; Lenihan D; Lindenfeld J; Maitland ML; Remick SC; Tang WH
    Am Heart J; 2012 Feb; 163(2):156-63. PubMed ID: 22305831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renovascular effects of antiangiogenic drugs].
    Deray G; Janus N; Aloy B; Launay-Vacher V
    Bull Cancer; 2016; 103(7-8):662-6. PubMed ID: 27318610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of hypertension in angiogenesis inhibitor-treated patients.
    Izzedine H; Ederhy S; Goldwasser F; Soria JC; Milano G; Cohen A; Khayat D; Spano JP
    Ann Oncol; 2009 May; 20(5):807-15. PubMed ID: 19150949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors.
    Tocchetti CG; Gallucci G; Coppola C; Piscopo G; Cipresso C; Maurea C; Giudice A; Iaffaioli RV; Arra C; Maurea N
    Eur J Heart Fail; 2013 May; 15(5):482-9. PubMed ID: 23325019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteinuria and hypertension with tyrosine kinase inhibitors.
    Kandula P; Agarwal R
    Kidney Int; 2011 Dec; 80(12):1271-7. PubMed ID: 21900879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.